Kevin Sean Murnane

NIH Rank #741
  • Top 5% by Linked Awards
  • R01 Award PI

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9297195Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Anatomy & Cell Biology

NIH Funding · FY2026

Linked Award Amount
$3.8M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#741
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Kevin Sean Murnane as a PI. Multi-PI records show the full award amount for context.

  • 5UG3DA061709-02UG3
    IND-enabling studies and phase I clinical trials to advance CD74-target, DRhQ, as a treatment for stimulant use disorder
    $3.3M
    award amount
  • 5R01DA061433-03R01
    Investigations into 5-HT2A signaling mechanisms of psychedelic drugs for the treatment of stimulant use disorder
    $480.5K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Kevin Sean Murnane as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2024
    $500K Cumulative Linked Award Amount
  3. 2024
    $1M Cumulative Linked Award Amount
  4. 2024
    Reached Top 50% by Award-Linked Rank
    Ranked #9942
  5. 2025
    $2M Cumulative Linked Award Amount
  6. 2025
    $5M Cumulative Linked Award Amount
  7. 2025
    Reached Top 25% by Award-Linked Rank
    Ranked #1874
  8. 2025
    Reached Top 10% by Award-Linked Rank
    Ranked #1874
  9. 2025
    Multiple Award Organizations
    Awards administered by 2 organizations
  10. 2025
    R01 Award Record
  11. 2026
    Reached Top 5% by Award-Linked Rank
    Ranked #741